Investor Presentaiton

Blood-based screening will change the cancer screening landscape Metastatic 14% Survival Statistics from 26 different cancers comprising 87% of all cancers in U.S. QA ☑ INVESTOR 20 Pleasant Consumer Experience High Performance MCED Test Local 90% Survival Regional 65% Survival DAY 23 GUARDANT Sources: SEER.cancer.gov.. Siegel, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48 98

View entire presentation